Clinical Trials Logo

Mobile Applications clinical trials

View clinical trials related to Mobile Applications.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT06014918 Recruiting - Pain, Postoperative Clinical Trials

App for Acute Pain Service in Major Surgery

Start date: August 28, 2023
Phase: N/A
Study type: Interventional

The app will be installed on the patient's smartphone before surgery. Patients will receive reminders to record their pain intensity and opioid-related side effects at the pre-determined time points until at least 2 days after surgery. The patient's compliance with the reminders will be assessed. On the second postoperative day, their satisfaction with pain control and app usage will be evaluated. Patients can also provide feedback on any issues they have encountered with the app during the study period.

NCT ID: NCT05946070 Recruiting - Cancer Clinical Trials

Effectiveness of Mobile Based Monitoring System in the Management of Chemotherapy-Related Symptoms

Start date: June 23, 2023
Phase: N/A
Study type: Interventional

Mobile health applications open the door to a safe and effective health system. Mobile communication channels and mobile phones not only provide training paths to healthcare professionals, but also provide remote decision support using automated data analysis or the ability to engage in real-time interviews with experts(1). The prevalence of symptoms due to cancer treatment and this adversely affect the quality of life and vital functions of patients and their relatives, and the increase in non-treatment admissions to the hospital. This shows that there is a need for programs where patients can control symptoms related to oncological treatment at home. It is thought that the use of mobile applications can be cost-effective by increasing access to health services and improving diagnosis, treatment and rehabilitation (2). Our single-blind, randomized-controlled, experimental study will be carried out between April 2022 and December 2022 at Kocaeli University Oncology and Palliative Care Center Ambulatory Chemotherapy Unit. The population of the study will consist of chemotherapy patients who applied to the unit and agreed to participate in the study. Based on the calculation made, it was decided to include 212 patients. In this context, it is thought that the mobile-based monitoring system in the management of chemotherapy-related symptoms will contribute to the management of treatment-related symptoms and increase the quality of life in patients receiving chemotherapy. Expected results from the use of the mobile application; - reducing the symptom burden, - improving the quality of life, - enabling informed changes in clinical practice and care, - reducing the social and economic burdens of cancer care.

NCT ID: NCT05055700 Recruiting - Pregnant Women Clinical Trials

Impact of a Mobile App on Pregnant Women's Prenatal Genetic Testing Decision-making

Start date: April 1, 2021
Phase: N/A
Study type: Interventional

Determine the effect of a culturally sensitive prenatal genetic testing (PGT) education intervention delivered via a mobile application on pregnant women's perceptions, knowledge, and uptake of PGT. Our working hypothesis, based on prior studies, is that pregnant women who receive a culturally sensitive intervention to enhance their knowledge and understanding of PGT will feel more confident in their decision-making regarding PGT.

NCT ID: NCT04787783 Recruiting - Mobile Applications Clinical Trials

Evaluation of the Utility of Preanestes@s, a Web Based Application for Preoperative Assessment

Preanestes@s
Start date: April 12, 2021
Phase: N/A
Study type: Interventional

In this prospective two-arm study, the investigators will evaluate the incidence of suboptimal preoperative assessments when the participants are evaluated through a web based application (Preanestes@s) versus the traditional outpatient interview.

NCT ID: NCT04653532 Recruiting - Clinical trials for Diabetes Mellitus, Type 2

Mobile Health to Enhance Exercise in Type 2 Diabetes

MOTIVATET2D
Start date: February 1, 2021
Phase: N/A
Study type: Interventional

Being physically active and exercising is important for the treatment of Type 2 diabetes as it helps control blood sugar and improve physical function. Lots of people find it hard to be physically active and sticking with exercise is difficult for most people. In this project we will investigate two strategies to support people with Type 2 diabetes to increase and then maintain a physically active lifestyle, which includes exercising regularly. Participants in one group (Exercise Counselling) will complete a 6-month structured exercise and physical activity programme supported by regular (virtual) contact with an exercise specialist. Participants in the second group (Mobile health technology (mHealth)) will receive the same 6-month exercise and physical activity programme supported by an exercise specialist, but participants in this group will also receive a fitness watch that links to a mobile phone application (App). The fitness watch and mobile App will allow the exercise specialist to provide greater support and feedback throughout the programme.

NCT ID: NCT03750084 Recruiting - Anesthesia Clinical Trials

Anaesthesia and mHealth

Start date: January 7, 2019
Phase:
Study type: Observational

This survey aims to better define the wishes/needs of the Belgian Anaesthesiologists within the field of mobile technology, namely, what would help improve the daily anaesthesia practice.

NCT ID: NCT02432469 Recruiting - Clinical trials for Medication Adherence

Quality Measurement and Improvement Study of Surgical Coronary Revascularization: Medication Adherence

MISSION-2
Start date: June 2015
Phase: N/A
Study type: Interventional

The study is a randomized controlled trial, having a plan to recruit 1000 patients underwent coronary artery bypass grafting in 1 of 5 participating sites in 2015, and randomized to either the intervention group or control group, to test the effectiveness of a smartphone based application (APP) focusing on improving patients medication adherence. Patients randomized to the intervention group install the APP in their smartphones with personnel information and physicians' medication descriptions. The APP reminds at the time of taking medications, educates them on secondary prevention for coronary artery disease, and collects their weekly situations by questionaires. Investigators will follow-up patients by face to face or telephone interview. The 6-month effects of the intervention are evaluated.